Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.93 USD | +0.63% | -0.63% | +72.97% |
05-09 | Larimar Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-09 | Zafgen, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+72.97% | 503M | |
+7.45% | 111B | |
+11.22% | 106B | |
-12.49% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.70% | 16.81B | |
+37.63% | 12.54B | |
-24.41% | 8.09B |
- Stock Market
- Equities
- LRMR Stock
- News Larimar Therapeutics, Inc.
- Larimar Therapeutics : William Blair Initiates Coverage on Larimar Therapeutics With Outperform Rating